New growth strategy and supply chain management system in place for SAFC, says president Gilles Cottier

By Natalie Morrison and Claire Videau

- Last updated on GMT

SAFC announced its new aggressive growth strategy, including plans to expand in the developing markets, at its conference in Irvine, Glasgow last week.

The firm has made around $100m (€73m) worth of investments over the past 18 months, including upgrades in fermentation at their plant in Israel, as well as developments in their packaging and QC sectors in India, China and Brazil.

When president Gilles Cottier spoke to Outsourcing-Pharma, he said that the company– who focus on custom-manufacturing, custom-packaging and customized raw-material supply services within Sigma-Aldrich – is now expanding in two main markets; biopharmaceuticals, and electronics.

And as part of plans to expand in the BRIC market (Brazil, Russia, India, China) Cottier also spoke of new supply chain management measurements.

He also discussed SAFC’s expanded capabilities in media manfucaturing, including a focus on liquid media capabilities at the Irvine facility.

Related news

Show more

Related products

show more

Powered by Ingredients + Innovation

Powered by Ingredients + Innovation

Content provided by Univar Solutions USA | 07-Oct-2024 | Product Brochure

In partnership with our industry-leading supplier partners, Univar Solutions Pharmaceutical Ingredients is proud to introduce Powering Healthy Tomorrows.

Reliability, scale, and security of supply

Reliability, scale, and security of supply

Content provided by Univar Solutions USA | 28-Aug-2024 | Product Brochure

Univar Solutions Pharmaceutical Ingredients is proud to offer one of the most expansive portfolios of 15,000+ products, including high-purity solvents,...

Ultra Low Temperature Packaging solutions

Ultra Low Temperature Packaging solutions

Content provided by Almac Group | 12-Feb-2024 | Case Study

Advanced Therapy Medicinal Products (ATMPs) offer ground-breaking opportunities for treating injuries and disease, in particular for cases of severe, untreatable...

Related suppliers

Follow us

Products

View more

Webinars